Address : Kivipylväänkuja, Espoo, Finland
Phone Number : +358 50 0512934
Industries : Pharmaceuticals
Website : desentum.fi
Company Description
Desentum is a clinical-stage, research-oriented biopharmaceutical company specialized in developing novel types of allergy immunotherapy products (aka allergy vaccines) that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. We have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivity reaction, we have made discoveries that allow for improved design of vaccines against common types of allergies. Our goal is to provide long-term relief from allergic symptoms with only a few months of treatment, as well as reduce the social and economic burden allergies cause to both individuals and society.
Specialities
- Immunotherapy & Allergy Vaccines
- Pharmaceutical Manufacturing
- Pharmaceuticals
- Medical
Financial
Employees Total : 7
Revenue (Yearly) : 5M
Total Funding : 20M
Latest Funding : 9.1M
Miscellaneous
Founded in : 2011
Twitter : desentumAIT
Linkedin : desentum-oy
Email Delivery : MailJet
Email Providers : Outlook
Tech : Microsoft Office 365
CSS and JavaScript Libraries : Bootstrap Framework
Tag Management : Google Tag Manager
Email Marketing : MailChimp
Last Updated : 2023-12-03
You Might Be Interested With:
 | LEBAG Leitungs- und Elektrobau AG Utilities |
 | Maui Estates International Lahaina, Hawaii, United States |
 | Elite Towing Fountain Valley, California, United States |
 | ProfitTrust New York, United States Financial Services |
 | GDL Productions Inc Las Vegas, Nevada, United States Entertainment |
 | International Investments |